Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 31Recruiting 11Unknown 4Not yet recruiting 4Withdrawn 3Enrolling by invitation 3Active not recruiting 3Terminated 2Available 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Head & Neck 3Endocrine 1CNS 1

Conditions

Breast Neoplasms 437Neoplasms 322Carcinoma, Non-Small-Cell Lung 250Prostatic Neoplasms 240Lung Neoplasms 174Colorectal Neoplasms 156Pancreatic Neoplasms 148Neoplasm Metastasis 142Leukemia, Myeloid, Acute 140Multiple Myeloma 130Lymphoma 127Carcinoma, Hepatocellular 127Ovarian Neoplasms 109Melanoma 109Brain Neoplasms 101Recurrence 100Head and Neck Neoplasms 100Leukemia, Lymphocytic, Chronic, B-Cell 96Leukemia 96Precursor Cell Lymphoblastic Leukemia-Lymphoma 90Glioblastoma 85Lymphoma, Non-Hodgkin 83Colonic Neoplasms 79Squamous Cell Carcinoma of Head and Neck 76Lymphoma, Follicular 76Carcinoma, Renal Cell 74Lymphoma, Large B-Cell, Diffuse 71Hematologic Neoplasms 69Sarcoma 60Stomach Neoplasms 58

Interventions

lutetium Lu 177 dotatate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Parathyroid Neoplasms × Clear all
NCT03516747 2022-04-11

Preoperational Fine Needle Aspiration of Pathological Parathyroid Gland

HaEmek Medical Center, Israel

Phase NA Withdrawn
Head & Neck

Hypercalcemia, Parathyroid Neoplasms

NCT04106843 2020-09-07

Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers

M.D. Anderson Cancer Center

Phase 2 Withdrawn
CNSEndocrineHead & Neck

Paraganglioma, Parathyroid Neoplasms, Pheochromocytoma, Pituitary Neoplasms, Carcinoma, Medullary

NCT02381925 2015-09-21

Multicenter Registry Comparing Preoperative Imaging for Primary Hyperparathyroidism

Duke University

Withdrawn
Head & Neck

Parathyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡